REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bioeterna S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bioeterna S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Bioeterna S.A. is a company in Ecuador, with a head office in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Bioeterna S.A. was incorporated on June 28, 2017. It currently has a total number of 4 (2023) employees. From the latest financial highlights, Bioeterna S.A. reported a net sales revenue drop of 40.61% in 2023. Its’ total assets recorded a growth of 3.91%. In 2023, Bioeterna S.A.’s net profit margin increased by 13.82%.

Headquarters
Av. Septima 02, Hotel Georston Bldg.
Guayaquil; Guayas;

Contact Details: Purchase the Bioeterna S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Bioeterna S.A. report to view the information.
Outstanding Shares:
Purchase the Bioeterna S.A. report to view the information.
Registered Capital:
Purchase the Bioeterna S.A. report to view the information.
Incorporation Date:
June 28, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Bioeterna S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-40.61%▼
Total operating revenue
-40.61%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
623.75%▲
Total assets
3.91%▲
Total equity
135.18%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
13.82%▲
Return on Equity (ROE)
38.8%▲
Quick Ratio
0.04%▲
Cash Ratio
0.02%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo